Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Femoral Fractures D005264 7 associated lipids
Weight Gain D015430 101 associated lipids
Hyperemia D006940 25 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Acidosis D000138 13 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
von Aulock S et al. Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo. 2003 J. Immunol. Methods pmid:12799039
Yregård L et al. Influence of local anaesthetics on inflammatory activity postburn. 2003 Burns pmid:12781610
Vigorita MG et al. Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling. 2003 Bioorg. Med. Chem. pmid:12614885
Vass G et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. 2003 Am. J. Respir. Crit. Care Med. pmid:12493648
Gama de Abreu M et al. One-lung ventilation with high tidal volumes and zero positive end-expiratory pressure is injurious in the isolated rabbit lung model. 2003 Anesth. Analg. pmid:12505956
Szebeni J et al. Complement activation during hemorrhagic shock and resuscitation in swine. 2003 Shock pmid:14501949
Vani G et al. Histone H1 modulates immune status in experimental breast cancer. 2003 Chemotherapy pmid:14504437
Xia Z et al. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. 2003 J. Thorac. Cardiovasc. Surg. pmid:14666012
Chen L et al. Cyclooxygenase inhibitor blocks rebound response after NO inhalation in an endotoxin model. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12485821
Lombard JH et al. High-salt diet impairs vascular relaxation mechanisms in rat middle cerebral arteries. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12456391
Jones AE et al. Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12639842
Sheu JR et al. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments. 2003 Exp. Biol. Med. (Maywood) pmid:14681547
De La Cruz JP et al. Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers. 2003 Fundam Clin Pharmacol pmid:12803576
Guyton K et al. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. 2003 Shock pmid:12813370
Fujimoto Y et al. Effects of endocrine disruptors on arachidonic acid metabolism in rabbit platelets. 2003 Toxicol. Appl. Pharmacol. pmid:12781627
Stephenson AH et al. Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12609822
Cipollone F et al. Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. 2003 Circulation pmid:12515743
Fike CD et al. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12388340
Nagase T et al. A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12505870
Dai H et al. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty. 2003 Postgrad Med J pmid:13679549
Liu H et al. Clinical implication of the changes of cAMP, TXA2 and PGI2 in CSF of asphyxiated newborns. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:12973949
Hart RG et al. Aspirin dosage and thromboxane synthesis in patients with vascular disease. 2003 Pharmacotherapy pmid:12741431
Pfeiffer S et al. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. 2003 Transplantation pmid:12698079
Arifah AK et al. Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat. 2003 J. Vet. Pharmacol. Ther. pmid:12667184
Davì G et al. Platelet activation in obese women: role of inflammation and oxidant stress. 2002 Oct 23-30 JAMA pmid:12387653
Hayashi M et al. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. 2002 Nov-Dec Eur. J. Haematol. pmid:12460234
Wolfram RM et al. Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers. 2002 May-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:12144875
Alarayyed NA et al. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro. 2002 Aug-Sep Platelets pmid:12189011
Ersöz G et al. Effect of submaximal and incremental upper extremity exercise on platelet function and the role of blood shear stress. 2002 Thromb. Res. pmid:12676189
Connolly E et al. Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty. 2002 J. Pharmacol. Exp. Ther. pmid:11805196
Pinheiro RM and Calixto JB Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. 2002 Inflamm. Res. pmid:12558194
Saldeen P et al. Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism. 2002 J. Matern. Fetal. Neonatal. Med. pmid:12530613
Bermejo BP et al. Sesquiterpenes from Jasonia glutinosa: in vitro anti-inflammatory activity. 2002 Biol. Pharm. Bull. pmid:11824534
Ersöz G et al. The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. 2002 Thromb. Res. pmid:12590951
Küsters S et al. Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. 2002 Arzneimittelforschung pmid:11878205
Lassus P et al. Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infants. 2002 Early Hum. Dev. pmid:11893431
Venuto R et al. Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11893597
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Sheu JR et al. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. 2002 Anesthesiology pmid:11873041
Horiguchi T et al. Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. 2002 Arzneimittelforschung pmid:12442639
Zaitsu M et al. Induction of thromboxane A2 synthesizing enzymes in DMSO-induced granulocytic differentiation of HL-60 cells. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468261
Thomson M et al. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468270
Sheu JR et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. 2002 Br. J. Haematol. pmid:12472585
Fiorucci S et al. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. 2002 Circulation pmid:12473561
Rouvier J et al. Aspirin resistance. 2002 Circulation pmid:12473569
Celik I et al. Effects of ibuprofen on the physiology and outcome of rabbit endotoxic shock. 2002 BMC Infect. Dis. pmid:12445332
Dai CF et al. [Clinical and experimental study of treatment of nanmiqing capsule for chronic prostatitis]. 2002 Zhonghua Nan Ke Xue pmid:12479132
Khan I et al. Cyclooxygenase-2 inhibition and experimental colitis: beneficial effects of phosphorothioated antisense oligonucleotide and meloxicam. 2002 Scand. J. Gastroenterol. pmid:12523593
Miyataka M et al. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. 2002 Hypertension pmid:11897764
Leahy KM et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. 2002 Cancer Res. pmid:11830509
Ozaki N et al. Differential regulation of prostacyclin and thromboxane by dexamethasone and celecoxib during oxidative stress in newborn rabbits. 2002 Prostaglandins Other Lipid Mediat. pmid:12428679
Ma LP et al. Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia. 2002 J Assoc Acad Minor Phys pmid:11852667
De La Cruz JP et al. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. 2002 Br. J. Pharmacol. pmid:12429581
Canbaz M et al. Effects of tibolone on thromboxane B(2) levels in postmenopausal women. 2002 Gynecol. Obstet. Invest. pmid:11803222
Huang F et al. Anti-platelet and anti-thrombotic effects of triacetylshikimic acid in rats. 2002 J. Cardiovasc. Pharmacol. pmid:11791012
Bayorh MA et al. 1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. 2002 Peptides pmid:11814618
Jeng JH et al. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. 2002 Free Radic. Biol. Med. pmid:11978487
Streppa HK et al. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. 2002 Am. J. Vet. Res. pmid:16206787
Jiang Z et al. [The changes of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha(6-keto-PGF1 alpha) in the lungs of rats drowned in hypothermic-sea-water]. 2002 Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi pmid:14694611
Saareks V et al. Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. 2002 Pharmacol. Toxicol. pmid:12403056
Kudolo GB et al. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. 2002 Thromb. Res. pmid:12590952
Sinzinger H Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12445490
Obase Y et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. 2002 Chest pmid:11796443
Gordon SM et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. 2002 Clin. Pharmacol. Ther. pmid:12189364
Van Hecken A et al. Effects of enteric-coated, low-dose aspirin on parameters of platelet function. 2002 Aliment. Pharmacol. Ther. pmid:12197849
Gómez-Gaviro MV et al. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. 2002 J. Biol. Chem. pmid:12147693
Khan AA et al. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. 2002 Clin. Pharmacol. Ther. pmid:12152003
Vecino AM et al. Phospholipase A2 activity in platelets of patients with uremia. 2002 Platelets pmid:12487789
Rinder HM et al. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial. 2002 J Clin Pharmacol pmid:12162470
Wong DA et al. Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). 2002 J. Exp. Med. pmid:12163563
Kiemer AK et al. Inhibition of cyclooxygenase-2 by natriuretic peptides. 2002 Endocrinology pmid:11861506
Huang K et al. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. 2002 Atherosclerosis pmid:11947907
Hu X et al. [The influence of nasal continual positive airway pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome]. 2002 Zhonghua Jie He He Hu Xi Za Zhi pmid:11953098
Burleigh ME et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. 2002 Circulation pmid:11956125
Jankov RP et al. Thromboxane A(2) receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. 2002 Am. J. Respir. Crit. Care Med. pmid:12119234
Giardiello FM et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. 2002 N. Engl. J. Med. pmid:11932472
Signorello MG et al. Effect of homocysteine on arachidonic acid release in human platelets. 2002 Eur. J. Clin. Invest. pmid:11952814
Yamasaki M et al. No involvement of interleukin-5 or eosinophils in experimental allergic rhinitis in guinea pigs. 2002 Eur. J. Pharmacol. pmid:11937106
Eikelboom JW et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. 2002 Circulation pmid:11940542
Knijff-Dutmer EA et al. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. 2002 Rheumatology (Oxford) pmid:11961179
Hayashi M et al. The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. 2002 Acta Obstet Gynecol Scand pmid:11966476
Leese PT et al. Valdecoxib does not impair platelet function. 2002 Am J Emerg Med pmid:12098171
Tsukamoto H et al. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatography-mass spectrometry. 2002 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12076690
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Jung K et al. The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TXB(2) level in Korean postmenopausal women with hypercholesterolemia. 2002 J. Korean Med. Sci. pmid:12068132
Jung YS et al. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12054917
van Kraaij DJ et al. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. 2002 Br J Clin Pharmacol pmid:12047490
Appleyard CB et al. Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. 2002 Dig. Dis. Sci. pmid:12353846
Valeri CR et al. Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. 2002 Transfusion pmid:12430680
Wilner KD et al. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. 2002 J Clin Pharmacol pmid:12211219
Molina V et al. D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12213431
Koizumi T et al. Inhibition of endogenous nitric oxide during endotoxemia in awake sheep - effects of Nomega-nitro-l-arginine on the distribution of pulmonary vascular resistance and prostanoid products. 2002 Exp. Lung Res. pmid:12217213
Khan I et al. Altered expression of Na(+)/H(+) exchanger isoforms 1 and 3 in clipped and unclipped kidneys of a 2-kidney-1-clip Goldblatt model of hypertension. 2002 Nephron pmid:12218313
Yokoyama C et al. Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction. 2002 Circulation pmid:12403673
Evgenov OV et al. Methylene blue reduces pulmonary oedema and cyclo-oxygenase products in endotoxaemic sheep. 2002 Eur. Respir. J. pmid:12412689
Bergh K et al. Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue. 2002 J Ocul Pharmacol Ther pmid:12419090
Chen TL et al. [Effects of fast decompression on prostaglandins content in cerebral tissue of guinea pigs]. 2002 Space Med Med Eng (Beijing) pmid:12222577
Kim H et al. Effect of mannitol on Helicobacter pylori-induced cyclooxygenase-2 expression in gastric epithelial AGS cells. 2002 Pharmacology pmid:12393940
Shashikant MP et al. Physicochemical properties of perfluorochemical liquids influence ventilatory requirements, pulmonary mechanics, and microvascular permeability during partial liquid ventilation following intestinal ischemia/reperfusion injury. 2002 Crit. Care Med. pmid:12394959
Vaughan JE and Walsh SW Oxidative stress reproduces placental abnormalities of preeclampsia. 2002 Hypertens Pregnancy pmid:12517328